| Basics |
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines.
|
| IPO Date: |
March 26, 1990 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$32.65B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.38 | 1.32%
|
| Avg Daily Range (30 D): |
$0.37 | 1.52%
|
| Avg Daily Range (90 D): |
$0.30 | 1.49%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
7.74M |
| Avg Daily Volume (30 D): |
11.38M |
| Avg Daily Volume (90 D): |
10.26M |
| Trade Size |
| Avg Trade Size (Sh.): |
240 |
| Avg Trade Size (Sh.) (30 D): |
162 |
| Avg Trade Size (Sh.) (90 D): |
184 |
| Institutional Trades |
| Total Inst.Trades: |
79,814 |
| Avg Inst. Trade: |
$2.28M |
| Avg Inst. Trade (30 D): |
$3.32M |
| Avg Inst. Trade (90 D): |
$3.37M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
14 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.49M |
| Avg Closing Trade (30 D): |
$14.33M |
| Avg Closing Trade (90 D): |
$12.07M |
| Avg Closing Volume: |
262.85K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$.62
|
$.38
|
$.25
|
|
Diluted EPS
|
$.61
|
$.37
|
$.24
|
|
Revenue
|
$ 16.78B
|
$ 4.48B
|
$ 4.18B
|
|
Gross Profit
|
$ 8.4B
|
$ 2.3B
|
$ 2.1B
|
|
Net Income / Loss
|
$ 662M
|
$ 434M
|
$ 283M
|
|
Operating Income / Loss
|
$ 1.83B
|
$ 882M
|
$ 455M
|
|
Cost of Revenue
|
$ 8.37B
|
$ 2.18B
|
$ 2.07B
|
|
Net Cash Flow
|
$ -1115M
|
$ 42M
|
$ 464M
|
|
PE Ratio
|
46.29
|
|
|
| Splits |
|
Jul 01, 2004:
2:1
|
|
Dec 06, 2002:
2:1
|
|
Feb 23, 2000:
2:1
|
|
|
|
